Report
Oussema Denguir

Genkyotex : Just a few weeks until results of phase II trial in a rare liver disease (PBC)

>Second positive SMB in primitive biliary cholangitis (PBC) - Yesterday evening Genkyotex announced that it had received a positive opinion from the second meeting of the independent safety monitoring board (SMB) for phase II study with GKT831 in primitive biliary cholangitis (PBC). PBC is a rare liver disease, chronic and auto-immune in nature, which is characterised by inflammation of the small biliary channels of the liver. PCB triggers cholestasis which can develo...
Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Oussema Denguir

Other Reports from Oddo BHF
Matthias Desmarais
  • Matthias Desmarais

ResearchPool Subscriptions

Get the most out of your insights

Get in touch